SIMA Wealth Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.2K Hold
100
– – 0.02% 97
2026
Q2
$25.2K Hold
100
– – 0.02% 97
2026
Q1
$21.7K Hold
100
– – 0.02% 99
2025
Q4
$22.8K Hold
100
– – 0.02% 98
2025
Q3
$23.2K Hold
100
– – 0.02% 103
2025
Q2
$18.6K Hold
100
– – 0.02% 106
2025
Q1
$21K Hold
100
– – 0.02% 116
2024
Q4
$17.8K Hold
100
– – 0.02% 123
2024
Q3
$19.7K Hold
100
– – 0.02% 107
2024
Q2
$17.2K Buy
+100
New +$16.6K 0.02% 115

Other funds holding ABBV

SIMA Wealth Partners's ABBV Position: Q3 2026 in Review

SIMA Wealth Partners held its AbbVie (ABBV) position steady in Q3 2026 at 100 shares worth $26.2K. The position accounts for 0.02% of the portfolio, ranked #97.

SIMA Wealth Partners first reported a position in ABBV in Q2 2024 and has held it in 10 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • SIMA Wealth Partners held 100 shares of AbbVie worth $26.2K as of Q3 2026.
  • SIMA Wealth Partners left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.02% of SIMA Wealth Partners's portfolio in Q3 2026, its #97 holding.
  • SIMA Wealth Partners first reported a position in AbbVie in Q2 2024 and has held it in 10 quarters since.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on SIMA Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.